Pomalyst is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Celgene Corporation. The primary component is Pomalidomide.
Product ID | 59572-504_0e50dfc9-35ac-4b11-89f1-5c3653717c3d |
NDC | 59572-504 |
Product Type | Human Prescription Drug |
Proprietary Name | Pomalyst |
Generic Name | Pomalidomide |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2013-02-18 |
Marketing Category | NDA / NDA |
Application Number | NDA204026 |
Labeler Name | Celgene Corporation |
Substance Name | POMALIDOMIDE |
Active Ingredient Strength | 4 mg/1 |
Pharm Classes | Thalidomide Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2013-02-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204026 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-02-18 |
Marketing Category | NDA |
Application Number | NDA204026 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-02-18 |
Ingredient | Strength |
---|---|
POMALIDOMIDE | 4 mg/1 |
SPL SET ID: | 2b25ef01-5c9e-11e1-b86c-0800200c9a66 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
59572-501 | Pomalyst | pomalidomide |
59572-502 | Pomalyst | pomalidomide |
59572-503 | Pomalyst | pomalidomide |
59572-504 | Pomalyst | pomalidomide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
POMALYST 85885565 4388257 Live/Registered |
Celgene Corporation 2013-03-25 |
POMALYST 85150878 3980998 Live/Registered |
Celgene Corporation 2010-10-12 |